Aptose Biosciences
Dr. Mark Vincent was a co-founder and has been the chief executive officer of Sarissa, Inc. since 2000. Dr. Vincent has extensive industry experience as a consultant to Canadian and U.S. biotechnology and pharmaceutical companies. Previously, he served as a director of Drug Royalty Corporation and currently is a member of the scientific advisory boards for several biotechnology companies. Dr. Vincent is an associate professor of oncology at the University of Western Ontario, and a staff medical oncologist at the London Regional Cancer Program.
This person is not in the org chart
This person is not in any offices
Aptose Biosciences
Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address the unmet clinical needs in multiple hematologic malignancies.